Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy
Sign Up to like & getrecommendations! Published in 2018 at "Nature Communications"
DOI: 10.1038/s41467-018-05420-0
Abstract: In patients with Charcot–Marie–Tooth disease 1A (CMT1A), peripheral nerves display aberrant myelination during postnatal development, followed by slowly progressive demyelination and axonal loss during adult life. Here, we show that myelinating Schwann cells in a… read more here.
Keywords: cmt1a; myelin lipid; model cmt1a; potential therapeutic ... See more keywords